Evidence map›Paper›PMID 38381440›Full record

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2024

Systemic Biological Mechanisms of Neurocognitive Dysfunction in Long-Term Survivors of Childhood Hodgkin Lymphoma.

AnnaLynn M Williams, Wei Liu, Matthew J Ehrhardt, Sedigheh Mirzaei Salehabadi, Angela Panoskaltsis-Mortari, Nicholas S Phillips, Daniel A Mulrooney, Jamie E Flerlage, Yutaka Yasui, Deokumar Srivastava and 5 more

Open access · greenAbstract read
In one paragraph

Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

AnnaLynn M WilliamsDepartments of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0002-7042-5851
Wei LiuDepartment of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0002-2447-8792
Matthew J EhrhardtDepartments of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0003-2781-9983
Sedigheh Mirzaei SalehabadiDepartment of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0001-8240-5957
Angela Panoskaltsis-MortariDepartments of Pediatrics and Medicine, University of Minnesota, Minneapolis, Minnesota.ORCID 0000-0003-1802-1785
Nicholas S PhillipsDepartments of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0002-2021-4036
Daniel A MulrooneyDepartments of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0003-2351-9115
Jamie E FlerlageDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0002-4182-9355
Yutaka YasuiDepartments of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0002-7717-8638
Deokumar SrivastavaDepartment of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0001-6693-8120
Leslie L RobisonDepartments of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0001-7460-8578
Melissa M HudsonDepartments of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0001-6984-2407
Kirsten K NessDepartments of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0002-2084-1507
Noah D SabinDepartment of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0002-7584-2574
Kevin R KrullDepartment of Psychology and Biobehavioral Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0002-0476-7001
St. Jude Children's Research Hospital · USUniversity of Minnesota · US

Funding

URCC NCORP Research BaseUG1CA189961 · NCI · UNIVERSITY OF ROCHESTER · PI Michelle C Janelsins, KAREN M. MUSTIAN · 2014 to 2026
$67.7M
The St. Jude Lifetime CohortU01CA195547 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI HUDSON, MELISSA M, NESS, KIRSTEN KIMBERLIE · 2015 to 2024
$14.9M
Brain Integrity in Survivors of Childhood Cancer Treated with Thoracic RadiationR01CA174794 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI KRULL, KEVIN R, SABIN, NOAH D. · 2013 to 2017
$3.1M
Training in Pediatric Cancer Survivorship Outcomes and InterventionsT32CA225590 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Kevin R Krull · 2018 to 2026
$2.4M
Aging-Related Biomarkers of Neurocognitive Function in Long-term Hodgkin Lymphoma SurvivorsR00CA256356 · NCI · UNIVERSITY OF ROCHESTER · PI WILLIAMS, ANNALYNN · 2022 to 2024
$655k
Aging-Related Biomarkers of Neurocognitive Function in Long-term Hodgkin Lymphoma SurvivorsK99CA256356 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI WILLIAMS, ANNALYNN · 2021 to 2022
$247k
Understanding neuropsychological and psychosocial sequelae in the elderly and in adolescent and young adult cancer survivorsK00CA222742 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI WILLIAMS, ANNALYNN · 2019 to 2020
$180k
NCI NIH HHS K00 CA222742NCI NIH HHS K99 CA256356NCI NIH HHS R00 CA256356NCI NIH HHS R01 CA174794NCI NIH HHS U01 CA195547NCI NIH HHS UG1 CA189961
6 · The paper itself

Abstract

purposeHodgkin lymphoma (HL) survivors experience neurocognitive impairment despite receiving no central nervous system-directed therapy, though little is known about the underlying mechanisms. EXPERIMENTAL

designHL survivors (n = 197) and age-, sex- and race/ethnicity frequency-matched community controls (n = 199) underwent standardized neurocognitive testing, and serum collection. Luminex multiplex or ELISA assays measured markers of inflammation and oxidative stress. Linear regression models compared biomarker concentrations between survivors and controls and with neurocognitive outcomes, adjusting for age, sex, race, body mass index, anti-inflammatory medication, and recent infections.

resultsHL survivors [mean (SD) current age 36 (8) years, 22 (8) years after diagnosis] demonstrated higher concentrations of interleukin-6 (IL6), high-sensitivity c-reactive protein (hs-CRP), oxidized low-density lipoprotein, and glutathione peroxidase (GPx), compared with controls (P's < 0.001). Among survivors, higher concentrations of IL6 were associated with worse visuomotor processing speed (P = 0.046). hs-CRP ≥3 mg/L was associated with worse attention, processing speed, memory, and executive function (P's < 0.05). Higher concentrations of malondialdehyde were associated with worse focused attention and visual processing speed (P's < 0.05). Homocysteine was associated with worse short-term recall (P = 0.008). None of these associations were statistically significant among controls. Among survivors, hs-CRP partially mediated associations between cardiovascular or endocrine conditions and visual processing speed, whereas IL6 partially mediated associations between pulmonary conditions and visuomotor processing speed.

conclusionsNeurocognitive function in long-term survivors of HL appears to be associated with inflammation and oxidative stress, both representing potential targets for future intervention trials.

Indexed as

BiomarkersCancer SurvivorsHodgkin DiseaseOxidative StressAdolescentAdultCase-Control StudiesChildC-Reactive ProteinFemaleHumansInflammationInterleukin-6MaleMiddle AgedNeurocognitive DisordersBiomarkersC-Reactive ProteinInterleukin-6

Identifiers

PMID38381440
PMCPMC11062814
OpenAlexW4391994299

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.